Skip to content
Screener

DexCom DXCM Q1 2025 earnings

Reported May 1, 2025 · After market close

Revenue$1.0BBeat by $18.6M
EPS$0.32Miss by $0.01
Revenue estimate$1.0B
EPS estimate$0.33

Next report

Oct 29, 2026 (in 2 months)
Revenue estimate$1.3B
EPS estimate$0.66

Financials

Q1 2025

Income statement

See full
Revenue$1.0B+12.5%
Gross profit$589.0M+4.8%
Operating income$133.7M+32.2%
Net income$105.4M-28.0%
EPS (diluted)$0.27-25.0%

Balance sheet

See full
Cash & equivalents$906.1M+6.3%
Total debt$139.9M-9.2%
Total equity$2.3B+0.9%
Total assets$6.8B+4.2%

Cash flow

See full
Operating cash flow$183.8M-12.1%
CapEx$87.0M+52.9%
Free cash flow$96.8M-36.4%

Valuation & ratios

Valuation

as of 03/31/25
See full
Market cap$26.78B-49.9%
Enterprise value$26.01B-50.7%
P/E50×-33.6×
P/S6.5×-7.6×

Profitability

See full
Gross margin59.4%-3.4pp
Operating margin15.3%-1.9pp
Net margin12.9%-3.9pp
FCF margin13.9%-1.5pp

Returns & leverage

See full
Return on equity23.7%-4.8pp
Debt / equity0.1×0.0×
Current ratio1.5×-1.4×

Segments

By geography

See full
United States$750.5M—

FAQ

When did DexCom report Q1 2025 earnings?
DexCom (DXCM) reported Q1 2025 earnings on May 1, 2025 after market close.
What were DexCom's Q1 2025 revenue and EPS?
DexCom reported revenue of $1.0B and eps of $0.32 for Q1 2025.
Did DexCom beat estimates in Q1 2025?
Revenue beat the consensus estimate of $1.0B by $18.6M. EPS missed the consensus estimate of $0.33 by $0.01.
How did DexCom's Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 12.5% from $921.0M a year earlier and eps grew 0.0% from $0.32.
Where can I find DexCom's Q1 2025 SEC filings?
You can read the 8-K earnings release (0001093557-25-000111) and the 10-Q periodic report (0001093557-25-000113) directly on SEC EDGAR. The filing index links above go to sec.gov.